Stockreport

Genmab scraps development of experimental cancer therapy [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF The ?company had assumed sole responsibility for the development and potential commercialization of ?acasunlimab in 2024, after BioNTech opted not to continue studying [Read more]